Neumann Diagnostics is a data driven biotech company. Neumann developed a test method which turns the clinical sample into data that can be objectively interpreted. This is the world’s most advanced cervical cancer screening technology.
Neumann’s aim is to make this test available to clinicians and patients who can both benefit from it.
Clinicians will receive results which are easy to act upon and an interpretation of the results which can be passed on to the patients.
The patients will be more informed and therefore more comfortable with the process. And most importantly, cervical cancer will be prevented.
Disclaimer
© 2024 Neumann Diagnostics Ltd.
